Risk factors for the failure of first‐line PARP inhibitor maintenance therapy in patients with advanced ovarian cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA‐3004)

OBJECTIVE: To identify the risk factors for failure of first‐line poly (ADP‐ribose) polymerase inhibitor (PARPi) maintenance therapy in patients with advanced ovarian cancer. METHOD: Patients with stage III‐IV epithelial ovarian cancer who received first‐line PARPi maintenance therapy were retrospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Nam Kyeong, Kim, Yeorae, Kim, Hee Seung, Park, Soo Jin, Hwang, Dong Won, Lee, Sung Jong, Yoo, Ji Geun, Chang, Suk‐Joon, Son, Joo‐Hyuk, Kong, Tae‐Wook, Kim, Jeeyeon, Shim, Seung‐Hyuk, Lee, A Jin, Suh, Dong Hoon, Lee, Yoo‐Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10587974/
https://www.ncbi.nlm.nih.gov/pubmed/37768030
http://dx.doi.org/10.1002/cam4.6546

Ejemplares similares

Ejemplares similares